Review Articles On Islet Cell Carcinoma
A pancreatic islet cell
tumor is a
tumor that is developed in the pancreas from a cell called an islet cell. These
cells are responsible for the production and secretion of
hormones like insulin and glucagon. These
hormones are then released into the circulatory system. Other names of islet cell
carcinoma are islet of Langerhans tumor, pancreatic endocrine tumor, and
neuroendocrine tumor. An islet cell
tumor can be non-cancerous or cancerous. Depending on the type of islet cell tumor, an overproduction of specific
hormones can be resulted. An islet cell
tumor is very uncommon; however it can cause various symptoms depending upon the kind of
hormone that it produces. If the
tumor is cancerous, and spreads to different parts of the body, the
malignancy can turn out to be intense. Review
articles on islet cell
carcinoma examine and discusses about the researches published by others, instead of revealing new experimental outcomes. Review
articles on pancreas include, current debates, significant gaps in research, recent advances, etc.
High Impact List of Articles
-
A study investigating the pharmacokinetic properties of insulin degludec/insulin aspart in healthy Chinese subjects
Shi Aixin, Li Yang, Xie Panpan, Qi Wenyuan, Yang Lei, Xu Hongfei, Zhang Ran, Hanne Haahr*
Research Article: Diabetes Management
-
A study investigating the pharmacokinetic properties of insulin degludec/insulin aspart in healthy Chinese subjects
Shi Aixin, Li Yang, Xie Panpan, Qi Wenyuan, Yang Lei, Xu Hongfei, Zhang Ran, Hanne Haahr*
Research Article: Diabetes Management
-
Attitudes and barriers to insulin therapy: Is there a difference between developed countries and developing countries?
Mungrue K*, Lessey G, Tyson L & Williams D
Research Article: Diabetes Management
-
Attitudes and barriers to insulin therapy: Is there a difference between developed countries and developing countries?
Mungrue K*, Lessey G, Tyson L & Williams D
Research Article: Diabetes Management
-
The collateral benefits of noninsulin therapies for Type 2 diabetes
Erin D Roe, Natalie C Pon, Priscilla Hollander & Philip Raskin
Review Article: Diabetes Management
-
The collateral benefits of noninsulin therapies for Type 2 diabetes
Erin D Roe, Natalie C Pon, Priscilla Hollander & Philip Raskin
Review Article: Diabetes Management
-
New developments to optimize postprandial glucose control with insulin in patients with diabetes
Bastiaan E de Galan
Review Article: Diabetes Management
-
New developments to optimize postprandial glucose control with insulin in patients with diabetes
Bastiaan E de Galan
Review Article: Diabetes Management
-
Insulin resistance caused by a redox-associated hepatokine
Toshinari Takamura, Hirofumi Misu ,Shuichi Kaneko
Review Article: Diabetes Management
-
Insulin resistance caused by a redox-associated hepatokine
Toshinari Takamura, Hirofumi Misu ,Shuichi Kaneko
Review Article: Diabetes Management
Relevant Topics in Clinical